Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 7 | 18 | 7 | 0 | 0 |
| Cost of Goods | 412 | 1 | 11 | N/A | N/A |
| Gross Profit | -405 | 17 | -4 | N/A | N/A |
| Operating Expenses | 1,178 | 966 | 1,160 | 1,010 | 26,229 |
| Operating Income | -1,171 | -948 | -1,153 | -1,010 | -26,229 |
| Interest Expense | 0 | 262 | 260 | 271 | 269 |
| Other Income | 3,826 | -265 | -12,939 | 3 | -598 |
| Pre-tax Income | 2,655 | -1,475 | -14,352 | -1,278 | -27,096 |
| Net Income Continuous | 5,235 | -1,475 | -14,352 | -1,278 | -27,129 |
| Minority Interests | -10 | -5 | -6 | -11 | -25 |
| Net Income | $5,245 | $-1,470 | $-14,346 | $-1,267 | $-27,104 |
| EPS Basic Total Ops | 1.03 | -0.12 | -1.18 | -0.11 | -2.48 |
| EPS Basic Continuous Ops | 1.03 | -0.12 | -1.18 | -0.11 | -2.48 |
| EPS Diluted Total Ops | 1.03 | -0.12 | -1.18 | -0.11 | -2.17 |
| EPS Diluted Continuous Ops | 1.03 | -0.12 | -1.18 | -0.11 | -2.17 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.12 | -1.18 | -0.11 | -0.42 |
| EBITDA(a) | $-885 | $-660 | $-865 | $-727 | $-857 |